Line 144: |
Line 144: |
| Phytopica is a product containing a selection of Chinese herbs, which has been shown to be an efficaceous, safe and palatable treatment for atopic dermatitis in dogs<sup>4</sup>. However, only a 20-50% improvement in signs is achieved, and so Phytopica is best used in combination with other control strategies and anti-inflammatory drugs. | | Phytopica is a product containing a selection of Chinese herbs, which has been shown to be an efficaceous, safe and palatable treatment for atopic dermatitis in dogs<sup>4</sup>. However, only a 20-50% improvement in signs is achieved, and so Phytopica is best used in combination with other control strategies and anti-inflammatory drugs. |
| | | |
− | ====Hydrocortisone aceponate====
| |
− | Hydrocortisone aceponate is a topical glucocorticoid that relieves pruritus. The topical administration and the fact that hydrocotisone aceponate is metabolised in the dermis means that many of the traditional side-effects of glucocorticoid therapy are avoided<sup>4</sup>. The product is potent, and rapidly exerts its effects following application.
| |
| | | |
− | Early studies (unpublished) demonstrated good
| + | Hydrocortisone aceponate is a topical glucocorticoid that relieves pruritus. The topical administration and the fact that hydrocotisone aceponate is metabolised in the dermis means that many of the traditional side-effects of glucocorticoid therapy are avoided<sup>4</sup>. The product is potent, and rapidly exerts its effects following application. The formulation of the product makes it easy to apply, even to haired skin, and most animals only require every-other-day treatment. Adverse effects are rare, and only one dog has been reported to suffer a contact reaction. |
− | efficacy and safety in short term treatment of
| |
− | various pruritic disorders in dogs including
| |
− | pyotraumatic dermatitis and f lea allergic
| |
− | dermatitis. An open-label pilot study and
| |
− | preliminary findings from a randomized, doubleblind,
| |
− | placebo controlled study found that
| |
− | Cortavance® was effective and well-tolerated in
| |
− | managing canine AD. One dog has suffered a
| |
− | contact reaction, but adverse effects have not
| |
− | otherwise been noted. Once daily administration
| |
− | was sufficient to induce remission, after which a
| |
− | proportion of dogs can be maintained on every
| |
− | other day therapy. Twice weekly administration, | |
− | however, resulted in a relapse in most dogs.
| |
| | | |
| Antihistamines have some efficacy in the face of atopic dermatitis, and may have synergistic activity with essential fatty acids and glucocorticoids<sup>4</sup>. | | Antihistamines have some efficacy in the face of atopic dermatitis, and may have synergistic activity with essential fatty acids and glucocorticoids<sup>4</sup>. |